Literature DB >> 18370976

Identifying persons with treated asthma using administrative data via latent class modelling.

Robert J Prosser1, Bruce C Carleton, M Anne Smith.   

Abstract

OBJECTIVE: To develop a parsimonious model of the respiratory patient population in British Columbia (BC), Canada through latent class modelling (LCM), using administrative data records and to assess conventional case definitions for asthma in relation to model-based case selection. DATA SOURCES: 1996-2001 data from linked provincial databases containing fee-for-service physician billing records, hospital inpatient separation abstracts, and prescription drug purchase records for 1.9 million BC respiratory patients. STUDY
DESIGN: This is a retrospective methodological/descriptive study that assesses case definitions for asthma in terms of sensitivity and specificity using a model fitted to seven physician, hospital and medication utilization markers in place of a conventional gold standard. DATA COLLECTION: We computed values of the treatment markers for each of the 5 years for each patient aged 5-55 years who had had at least one occurrence of a respiratory diagnosis code. PRINCIPAL
FINDINGS: The marker for prescription of short-acting beta agonists (SABAs) consistently had the highest sensitivity. Markers' specificities ranged from 0.97 to 1.0. The conventional case definitions' sensitivities were 0.41-0.87; specificities ranged from 0.98 to 0.997. Model-based estimates of asthma prevalence increased from 827/10,000 in 1996 to 992/10,000 in 2001. Conventional case definitions' estimates were consistently lower.
CONCLUSIONS: The linkage between utilization and case status is more complex than conventional case definitions allow for. LCM-based case classification was consistent over time and tends to lead to larger prevalence estimates than conventional definitions. The estimated increases in asthma prevalence are reliable. LCM provides health services planners with a useful probability-based approach for developing and assessing case definitions and estimating case prevalence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18370976      PMCID: PMC2442362          DOI: 10.1111/j.1475-6773.2007.00775.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  19 in total

Review 1.  Defining asthma in epidemiological studies.

Authors:  J Pekkanen; N Pearce
Journal:  Eur Respir J       Date:  1999-10       Impact factor: 16.671

Review 2.  Continuing the debate about measuring asthma in population studies.

Authors:  J K Peat; B G Toelle; G B Marks; C M Mellis
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

3.  Methods for evaluating the performance of diagnostic tests in the absence of a gold standard: a latent class model approach.

Authors:  Elizabeth S Garrett; William W Eaton; Scott Zeger
Journal:  Stat Med       Date:  2002-05-15       Impact factor: 2.373

4.  Latent class model diagnosis from a frequentist point of view.

Authors:  Anton K Formann
Journal:  Biometrics       Date:  2003-03       Impact factor: 2.571

Review 5.  The global burden of asthma: executive summary of the GINA Dissemination Committee report.

Authors:  Matthew Masoli; Denise Fabian; Shaun Holt; Richard Beasley
Journal:  Allergy       Date:  2004-05       Impact factor: 13.146

6.  Latent class models for utilisation of health care.

Authors:  Teresa Bago d'Uva
Journal:  Health Econ       Date:  2006-04       Impact factor: 3.046

7.  The value of latent class analysis in medical diagnosis.

Authors:  D Rindskopf; W Rindskopf
Journal:  Stat Med       Date:  1986 Jan-Feb       Impact factor: 2.373

8.  The effect of conditional dependence on the evaluation of diagnostic tests.

Authors:  P M Vacek
Journal:  Biometrics       Date:  1985-12       Impact factor: 2.571

9.  Diagnosing asthma: the fit between survey and administrative database.

Authors:  Lisa Huzel; Leslie L Roos; Nicholas R Anthonisen; Jure Manfreda
Journal:  Can Respir J       Date:  2002 Nov-Dec       Impact factor: 2.409

10.  Stabilization of an increasing trend in physician-diagnosed asthma prevalence in Saskatchewan, 1991 to 1998.

Authors:  Ambikaipakan Senthilselvan; Joshua Lawson; Donna C Rennie; James A Dosman
Journal:  Chest       Date:  2003-08       Impact factor: 9.410

View more
  9 in total

1.  Use of Systematic Methods to Improve Disease Identification in Administrative Data: The Case of Severe Sepsis.

Authors:  Saeid Shahraz; Tara Lagu; Grant A Ritter; Xiadong Liu; Christopher Tompkins
Journal:  Med Care       Date:  2017-03       Impact factor: 2.983

2.  The impact of FDA regulatory activities on incident dispensing of LABA-containing medication: 2005-2011.

Authors:  Meghan A Baker; Melissa G Butler; Sally Seymour; Fang Zhang; Yute Wu; Ann Chen Wu; Mark S Levenson; Pingsheng Wu; Aarthi Iyer; Sengwee Toh; Solomon Iyasu; Esther H Zhou
Journal:  J Asthma       Date:  2017-10-13       Impact factor: 2.515

3.  Direct health care costs associated with asthma in British Columbia.

Authors:  Mohsen Sadatsafavi; Larry Lynd; Carlo Marra; Bruce Carleton; Wan C Tan; Sean Sullivan; J Mark Fitzgerald
Journal:  Can Respir J       Date:  2010 Mar-Apr       Impact factor: 2.409

4.  Fine particulate air pollution, nitrogen dioxide, and systemic autoimmune rheumatic disease in Calgary, Alberta.

Authors:  Sasha Bernatsky; Audrey Smargiassi; Markey Johnson; Gilaad G Kaplan; Cheryl Barnabe; Larry Svenson; Allan Brand; Stefania Bertazzon; Marie Hudson; Ann E Clarke; Paul R Fortin; Steven Edworthy; Patrick Bélisle; Lawrence Joseph
Journal:  Environ Res       Date:  2015-05-16       Impact factor: 6.498

5.  Surveillance of systemic autoimmune rheumatic diseases using administrative data.

Authors:  S Bernatsky; L Lix; J G Hanly; M Hudson; E Badley; C Peschken; C A Pineau; A E Clarke; P R Fortin; M Smith; P Bélisle; C Lagace; L Bergeron; L Joseph
Journal:  Rheumatol Int       Date:  2010-07-28       Impact factor: 2.631

6.  Comparing administrative and survey data for ascertaining cases of irritable bowel syndrome: a population-based investigation.

Authors:  Lisa M Lix; Marina S Yogendran; Souradet Y Shaw; Laura E Targownick; Jennifer Jones; Osama Bataineh
Journal:  BMC Health Serv Res       Date:  2010-02-01       Impact factor: 2.655

7.  Long-Term Natural History of Severe Asthma Exacerbations and Their Impact on the Disease Course.

Authors:  Tae Yoon Lee; John Petkau; Mohsen Sadatsafavi
Journal:  Ann Am Thorac Soc       Date:  2022-06

8.  Trends in oral corticosteroids use in severe asthma: a 14-year population-based study.

Authors:  Mohsen Sadatsafavi; Amir Khakban; Hamid Tavakoli; Solmaz Ehteshami-Afshar; Larry D Lynd; J Mark FitzGerald
Journal:  Respir Res       Date:  2021-04-09

9.  Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study.

Authors:  Pierrick Bedouch; Mohsen Sadatsafavi; Carlo A Marra; J Mark FitzGerald; Larry D Lynd
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.